Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

David R. Minor; Samantha P. Moores; John K. Chan

首页> 外文期刊>Gynecologic Oncology Reports >Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

【24h】

Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

机译：腹膜内白介素2免疫疗法治疗复发性卵巢癌后延长生存期

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Highlights ? A case report of a 14year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented. ? Intraperitoneal IL-2 was given with little toxicity. ? Immunotherapy may have the potential for durable remissions in ovarian cancer.

机译：强调？本文报道了腹膜内白细胞介素（IL-2）复发卵巢癌14年的病例报告。？腹腔注射IL-2的毒性很小。？免疫疗法可能具有持久缓解卵巢癌的潜力。

著录项

来源
《Gynecologic Oncology Reports》 |2017年第1期|共2页
作者
David R. Minor; Samantha P. Moores; John K. Chan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [J] . Petrillo M., De Iaco P., Cianci S., Annals of surgical oncology . 2016,第5期

机译：二次细胞还原手术加高温腹膜内化疗（HIPEC）治疗的铂敏感性复发性卵巢癌患者的长期生存
2. Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study. [J] . Jean-Fran?ois Le Brun, Loic Campion, Dominique Berton-Rigaud, Annals of surgical oncology . 2014,第11期

机译：腹膜高温化疗对复发性卵巢癌的生存益处：多机构病例对照研究。
3. Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improves progression-free survival, especially in BRCA-positive patients-A case-control study [J] . SafraT., GrisaruD., InbarM., Journal of Surgical Oncology . 2014,第6期

机译：复发性卵巢癌的高剂量腹膜内化疗的细胞减少术可改善无进展生存期，特别是对于BRCA阳性患者-病例对照研究
4. Development of Interleukin-2 'Superkines' for Cancer Immunotherapy [C] . Rodrigo Vazquez-Lombardi, Daniela Zinkl, Jenny Jackson, PEGS . 2015

机译：癌症免疫疗法的白细胞介素-2'Superkines的开发
5. Characterization of granulocyte-macrophage colony-stimulating factor/interleukin-2 fusioncDNA and the use of marrow stromal cells for cancer immunotherapy. [D] . Stagg, John. 2006

机译：粒细胞巨噬细胞集落刺激因子/白细胞介素2融合cDNA的表征以及骨髓基质细胞在癌症免疫治疗中的应用。
6. Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer [O] . David R. Minor, Samantha P. Moores, John K. Chan 2017

机译：腹膜内白介素2免疫疗法治疗复发性卵巢癌后延长生存期
7. Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer [O] . David R. Minor, Samantha P. Moores, John K. Chan 2017

机译：腹腔白细胞介素-2免疫治疗复发性卵巢癌后存活时间延长

Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

摘要

著录项

相似文献

相关主题

期刊订阅